3 Firms Shape $384M Cancer Biopharma Co. Take-Private Deal
By McCord Pagan ( August 12, 2020, 6:44 PM EDT) -- Biopharmaceutical cancer research business Cellular Biomedicine Group said Wednesday it's agreed to be taken private by a group that includes current investors and members of its senior management team in a deal valuing the company at about $384 million that was guided by three law firms....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.